Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mesoblast International Sàrl
The long-term safety of human mesenchymal stem cells (hMSCs) (Chondrogen) has not yet been established. This 3-year follow-up study will provide additional data to gain understanding of the safety of the investigational agent. This study is designed to determine the safety of a single intra-articular injection of 50 million donor-derived hMSCs or 150 million donor-derived hMSCs in suspension with commercial sodium hyaluronan compared to an injection of vehicle (diluted hyaluronan) alone. The injections were performed under the initial study, Protocol No. 550.
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject must have received an injection in Protocol No. 550
Subject must have completed the 6-month and final 2-year visit in Protocol No. 550
Subject must provide written informed consent for entry into the extension study
Subject must provide authorization for use and disclosure of protected health information for entry into the extension study
